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Background. Calcium malabsorption after bariatric surgery may be harmful to skeletal health and demands for optimal skeletal
management. Methods. 103 Patients were evaluated retrospectively at 12 months after surgery. The evaluation included a
questionnaire about stool frequency and consistency and laboratory assessments. Results. 103 Patients, 27 males and 76 females,
wereincludedinthestudy. 83Patientshadanalimentarylimbof100cmand20patientsoneof150cm.At12monthsaftersurgery,
77.7% reported changes of bowel habits, albumin adjusted calcium levels were normal in all but 2 patients, and PTH levels were
increased in 35%. Correlations between semiquantiﬁed bowel scores (fecal scores) and data from the laboratory demonstrated
increasing PTH values along with more frequent and softer/watery stools (RR 30.5, CI 6.2–149.2, P<. 001). There was a trend
for higher PTH levels in patients with an alimentary limb of 150cm. Normal PTH levels were more frequently found in case of
calcium and vitamin D3 use (RR 14.3, CI 3.6–56.5, P<. 001). Conclusion. This study demonstrates interrelationships between
semi-quantiﬁed fecal scores, PTH levels, and the compliance of taking calcium/vitamin D3 suppletion. However, prospective
randomized studies are necessary to show causal relationships.
1.Introduction
Bariatric surgery still remains the most eﬀective treatment
for morbid obesity, leading to a reduction of comorbidities
in the long term [1]. Roux-en-Y-Gastric Bypass (RYGB) is
one of the most frequently performed procedures in the
United States and is also widely practiced in Europe [2–
4]. Calcium and vitamin D deﬁciencies, which frequently
arise after surgery, may be overlooked because of their slow
development. However, they may give rise to secondary
hyperparathyroidism (2◦HPT) as the body attempts to
counter the deﬁcits [5]. Obviously, suﬃcient dietary calcium
and vitamin D are necessary to preventthis condition, which
can be diﬃcult to achieve because of the bypassed proximal
part of the small intestine. This is the obvious reason for the
recommendation of supplying adequate amounts of dietary
calcium and vitamin D after surgery [6–8]. Long-lasting
2◦HPT for years is believed to be an important contributing
factor for increased bone turnover and consequent bone
loss. Indeed, epidemiologic data have shown that gastric
surgery can lead to a state of 2◦HPT with an increased risk
of osteoporotic fractures [9–11].
Besides inadequate dietary intake of calcium to compen-
sate for suboptimal calcium absorption, changes of bowel
habits after gastrointestinal surgery may also interfere. It is
of note that morbidly obese patients frequently have fecal
incontinence due to a rise in intra-abdominal pressure with
compression and stretch of the pelvic ﬂoor and of the
muscles and nerves around the anal sphincter complex and
in the vicinity of the supporting endopelvic fascia [12]. After
bariatric surgery, many patients initially experience less fecal
incontinence due to substantial weight loss and associated
improvements of intra-abdominal mechanics [13, 14]. For
obvious reasons, patientsmay evenhave a lowered frequency
and hardened consistency ofdefecation in comparison to the
situation prior to the operation. Nevertheless, more frequent2 Journal of Obesity
Table 1: Preoperative demographics and laboratory data prior to
gastric bypass surgery.
Parameters
Patient no. 103
Males/Females 27/761
Age (yr) 42.3 ± 9.7
BMI (Kg/m2) 48.6 ± 6.2
Body weight (Kg) 144.3 ± 21.9
Alimentary limb
Patient no.
with 100cm 83
Patient no.
with 150cm 20
Patients with
abnormallab.
values
Calcium
(mmol/L)2 2.31 ± 0.07 23
Vitamin D
(nmol/L) 50.4 ± 22.4
Insuﬃciency <30
(nmol/L) 18 (17%)
Deﬁciency <50
(nmol/L) 32 (31%)
PTH (pmol/L) 5.1 ± 1.0 10 (10%)
1The number of males versus females was statistically diﬀerent (P<. 05).
2Serum calcium was adjusted for albumin concentrations. 31P a t i e n th a da
corr. serum calcium of 2.63 and 1 patient of 2.10mmol/L.
and looser stools are common in operated patients [15–17].
Studies in laboratory animals elaborating on intestinal cal-
cium absorption have shown that intestinal calcium kinetics
depends on intestinal transit time [18]. Similar observations
were found after RYGB due to the inability of the small
intestine to bind and absorb calcium [19].
To our knowledge, no previous studies were published
about interactions between bowel habits after surgery and
changes of calciummetabolism. The aim of thepresentstudy
is to investigate relationships between semiquantiﬁed stools
scores according to patient reports, compliance for the daily
use of extra calcium, and calcium metabolism.
2.PatientsandMethods
During a period of 3 years, 423 morbidly obese patients
underwent laparoscopic RYGB. Patients were eligible for the
study if laboratory data were available at baseline and at
11 to 13 months after surgery. A total of 103 patients, 27
males and 76 females, were eligible, and these were invited to
discuss the purpose of the study; all consented to participate.
The objectives of the study were (1) to evaluate bowel habit
changes after surgery; (2) to evaluate relationships between
(1) and laboratory assessments; (3) to evaluate relationships
between (1) and (2) with the daily use of a formulation,
containing 1g of elementary calcium and 880 to 1000IU
Table 2: Biochemical data categorized according to normal or
increased PTH levels at 12 months after gastric bypass surgery.
PTH (pmol/L) PTH ≤ 6.8 PTH > 6.8 Normal
Patient no. 67 36
Calcium 2.34 ± 0.08 2.31 ± 0.11 2.10–2.55mmol/L
Vitamin D 47.5 ± 27.5 40.3 ± 20.3 30–100nmol/L
Albumin 38.6 ± 3.0 38.6 ± 4.0 35–50g/L
PTH 4.3 ± 1.4∗ 9.5 ± 2.8∗ 1.3–6.8pmol/L
Lab. results are represented as (mean ± 1SD). ∗Signiﬁcant by one-way
ANOVA with P<. 0001.
Vitamin D3. The medical ethical committee of Rijnstate
Hospital, Arnhem, The Netherlands approved the study.
All patients were planned for surgery. All patients under-
went surgeryin asingle centerfor bariatric surgery (Rijnstate
Hospital Alysis Zorggroep, The Netherlands). Laparoscopic
RYGB was performed by 2 dedicated bariatric surgeons who
used standard techniques. According to protocol, patients
with a BMI >40kg/m2 received a 45cm biliopancreatic
limb, and a 100cm alimentary limb, while patients with
aB M I>50kg/m2 received a 150cm alimentary limb. 20
Patients received a 150cm limb and 83 patients received
a 100cm limb. 22.2% of all males received a 150cm limb
versus 18.8% of all females, meaning no statistical diﬀerence
in sex distribution. Patients were advised to take daily
multivitaminsinadditiontoomeprazol40mg(oncedailyfor
6m o n t h s )[ 20] and low molecular heparin SC (fraxiparine
5700IU once daily for 6 weeks); patients were advised to
take a daily calcium/vitamin preparation (CaD 1000/880
sachets, containing calcium citrate and vitamin D3) or, if
they refused to take CaD, to try a diﬀerent formulation
containing calcium carbonate and vitamin D3 (Calcichew
500/400 chewing tablets b.i.d.).
After written informed consent, each participant was
requested to complete a questionnaire about his/her bowel
habits prior to and at 12 months after surgery. Fecal
frequency was scored on a ﬁve-point scale ranging from less
than twice a week (1 point), every two days (2 points), once
a day (3 points), twice a day (4 points) to more than twice a
day (5 points). In addition, fecal consistency was scored on a
ﬁve-point scale ranging from watery stools(5points), watery
tosolidstools(4points),normalstools(3points),ﬁrmstools
(2 points) to hard stools with concomitant constipation
(1 point). Summation of fecal consistency and frequency
scores yielded a “fecal score” (FS). Compliance in taking
additional calcium and vitamin D3 was arbitrarily deﬁned
as daily use with the maximal exception of one day per
week. Patients who reported taking the supplement for 5 or
less days a week were categorized as noncompliant. For the
current analysis, we recorded (1) compliance with regular
use of calcium and vitamin D3 containing formulations,
(2) the number of patients who requested to switch from
liquid formulations (sachets) to chewing tablets, and (3)
the number of patients who used laxatives or constipating
agents, at least weekly. Calcium, albumin, vitamin D, and
PTH at baseline (before surgery) and at 12 months after
surgery were used in the ﬁnal analysis of the study.Journal of Obesity 3
Table 3
(a) Changes of bowel habits according to frequency and consistency scores
before and after gastric bypass surgery
Time
Baseline 12mo. Baseline 12mo.
frequency frequency consistency frequency
Patient no. 103 103 103 103
Frequency/
Consistency
<2 per week/
constipated
9 6 12 8
3t i m e sp e r
week/ﬁrm
23 19 26 14
1d a y / n o r m a l 55 44 62 48
2p e r
day/solid to
watery
13 19 2 27
>2p e r
day/liquid
3 15 1 6
Number of patients with frequency and consistency scores ranging from 1
to 5 points.
(b) Fecal scores before and after gastric bypass surgery
Fecal score Baseline 12 Months
27 8
34 8
41 2 1 7
52 9 2 7
63 9 1 7
78 1 2
84 9
90 4
10 0 1
Fecal scores are the summation of stool frequency and consistency ranging
from 2 to 10 points and disclosed a signiﬁcant increase post surgery (γ2-
test: P<. 01).
2.1. Statistical Analysis. The datasheet was analyzed using
SPSS16, statistical software. All data are reported as mean ±
1SD unless otherwise speciﬁed; P<. 05 was considered sig-
niﬁcant. Results were compared using independent sample
t-tests, Chi square-tests, relative risk calculation, and one-
way ANOVA. Logistic regression was used to diﬀerentiate
between variables.
3.Results
Demographic data of the included 103 patients, prior to
surgery, are listed in Table 1. There were 27 males and 76
females (P<. 05). All patients were Caucasians. 8 Patients
(7.7%) were regular tobacco users, 12 patients were on
antidiabetic drugs (11.6%), and 1 patient used prednisone.
6 females were postmenopausal; 1 of them was on hormonal
replacement therapy.
2 Patients were diagnosed with a leakage at the gastroje-
junostomy and were oversewn successfully, respectively, on
the ﬁrst and third postoperative days. Both patients were
discharged within a week after the second operation. Other
2 patients had their gallbladder removed at 6 and 8 months
after surgery. There were no other surgical complications.
The excess weight loss (EWL) was >25% for the entire
group of 103 patients and exceeded more than half in 83
participants (81%).EWLof thetotalgroupat12months had
decreased by (mean ± 1SD) 63.5 ± 19.5%. The BMI of the
whole group decreased from 48.2±6.2kg/m 2 before surgery
to 33.9 ±5.5kg/m 2 at 12 months.
Serum calcium concentrations corrected for albumin
were normal in 101 patients (98%); vitamin D insuﬃciency
(<50nmol/L) was demonstrated in 63 patients of whom 32
patients(31%)had vitamin Ddeﬁciency(<30nmol/L). PTH
levels were increased (>6.8pmol/L) in 36 patients (35%), see
Table 2.
Notably, none of the patients were regular laxative users,
and 79 out of 103 patients (77.7%) reported permanent
changes of their bowel habits. Each patient estimated stool
frequency and consistency on two 5-point scales ranging
from stools less than twice a week to more than twice a
day and from watery to hard stools. The summation of
each score (frequency plus consistency scores) yielded a fecal
score (FS). Memorized stool frequency and consistency data
before surgery and at 12 months are listed in Table 3(a) and
the distribution of fecal scores (FS) (from 2 to 10 points)
in Table 3(b). Each score disclosed a signiﬁcant change
comparing frequency of stools (F), consistency of stools (C),
and the fecal score (FS). In general, there was a signiﬁcant
shift towards more frequent and less consistent stools, which
overall had resulted in higher fecal scores for (F: P<. 05, C:
P<. 0001, and FS: P<. 01).
Laboratory assessments disclosed no signiﬁcant changes
of corrected calcium and vitamin D levels (calcium before
surgery 2.31mmol/L and at 12 months 2.34mmol/L,
vitamin D before surgery 50.4nmol/L and at 12 months
45.0nmol/L), while mean PTH levels increased from 5.1
to 6.1pmol/L (P = .02). Before surgery, 10 patients had
increased PTH levels, while 4 of them (40%) had also
increased PTH levels at 12 months. Before surgery, 32 out of
93patientshadnormal PTHlevelsbutdevelopedraised PTH
levels at 12 months (34.4%) (NS). PTH levels compared for
each domain of stool habits (frequency (F), consistency (C),
and fecal score (FS)) per tertile at 12 months, showed no
signiﬁcant changes for F and C. However, PTH levels rose
signiﬁcantly along with tertile FS (RR 30.5, CI 6.2–149.2,
P<. 001), see Table 4.
At 12 months, calcium and vitamin D levels were
similar between patients with an alimentary limb of
100cm (n = 83) and 150cm (n = 20) (100cm: calcium:
2.31mmol/L, vitamin D 46nmol/L and 150cm: calcium:
2.33mmol/L, vitamin D 42nmol/L). In addition, there was a
trendtowardshigherPTHlevelsafterinclusionofallpatients
using two-sided Student t-test: 100cm: PTH: 5.6pmol/L
and 150cm: PTH 7.9pmol/L (P = .001). PTH levels were
not signiﬁcantly signiﬁcant after inclusion of compliant
calcium/vitamin D3 users (logistic regression) (RR 3.2, CI
0.9–11.8, P = .08). At 12 months, there were 36 patients
(35%) with increased PTH levels. 24 of these patients had a
100cmalimentary limb (67%),and 12 patientshad a 150cm
alimentary limb (33%).4 Journal of Obesity
Table 4: Laboratory results according to fecal scores calculated for each tertile.
Fecal score Low Intermediate High P-value
Patient numbers
(Point range per tertile fecal score)
33
(2–4)
44
(5-6)
26
(7–10)
Calcium (mmol/L)
(Patient numbers with hypocalcemia)
2.35 ± 0.09
(0)
2.32 ± 0.09
(0)
2.34 ± 0.11
(1) .43
Vitamin D
(<30nmol/L/<50nmol/L)
41 ± 21.0
(11/22)
51 ± 29.8
(11/25)
39.5 ± 20.4
(10/16) .12
PTH
(≥6.8pmol/L)
4.9 ± 2.3
(4)
5.8 ± 3.2
(13)
8.0 ± 3.4
(19) <.001
Patients with an alimentary limb of 150cm
(% of total)
3
(9)
10
(23)
7
(26) .17∗
∗P value by γ2-test, all other comparisons were performed by one-way ANOVA.
According to the deﬁnition used in the current study,
there were 82 compliant calcium/vitamin D3 users (80%).
High PTH levels (PTH >6.8pmol/L) were found in 21
patients who belonged to this group compliant for sup-
pletion (26%) against 15 patients who belonged to the 21
remaining noncompliant suppletion users (71%) (RR 14.3,
CI 3.6–56.5, P<. 001). In the subgroup of 36 patients
with high PTH levels, 21 patients (58%) were compliant
suppletion users (PTH: 9.2 ± 2.8pmol/L) and 15 patients
(42%) were not compliant (PTH: 9.9 ± 2.7pmol/L) (NS).
The reasons for noncompliant suppletion use were being
principally against regular use of any prescribed drug,
frequently forgetting, and taste aversion against calcium
formulations. 69 of the 82 compliant suppletionusers (84%)
had decided to switch from sachets (liquid formulation)
to chewing tablets, while the remaining 13 patients (16%)
continued to take sachets. The main reasons for changing
from sachets to tablets were nonpalatability reported by 54
patients (78%) and/or the inability to drink large volumes
reported by 30 patients (43%). There were 6 reports on
dumping-like symptoms with sachets.
4.Discussion
The results of the current study showed signiﬁcant changes
of bowel habits after surgery, which went into the direction
of a higher stool frequency, less consistency, and consequent
higher fecal scores. There were no correlations with either
frequency or consistency and PTH levels, while fecal score
and PTH levels were positively correlated. There was also
an interaction between compliance for calcium/vitamin
D3 suppletion and PTH levels, but it should be empha-
sized that the current results are nothing but associations,
which implicates that prospective intervention studies are
needed to clarify how these factors interact. Moreover, it is
entirely unclear whether additional calcium and vitamin D
supplements are beneﬁcial in suppressing PTH levels and
ultimately aﬀect incident osteoporotic fractures in later life.
An additional uncertainty is the eﬀect of omeprazol 40mg
(once daily for 6 months) on calcium metabolism after
surgery. Indeed, proton pump inhibitor therapy increases
the risk to skeletal fracture in the long term, possibly by
inhibiting intestinal calcium absorption [21, 22]. Obviously,
prospective randomized clinical trials should be long last-
ing as osteoporotic fractures usually occur much later in
life.
E l e v a t i o no fP T H ,e v e ni nt h ep r e s e n c eo fu n c h a n g e d
corrected calcium and vitamin D levels, is compatible with
2◦HPT [5] .I nf a c t ,R Y G Bs e r v e sa sam o d e lf o r2 ◦HPT
exclusivelyduetoinadequatecalciumabsorption. Astudyon
calcium metabolism of patients who had undergone RYGB
and matched controls showed that the patients needed an
extra amount of 750mg calcium per day to maintain similar
PTH levels [23] .T h e s ec a l c u l a t i o n sw e r em a d ea t9m o n t h s
after surgery, meaning that calcium metabolism was still
inﬂuenced by skeletal calcium eﬄuxes due to high bone
turnover [23, 24]. Yet, no calcium balance studies have been
published that deal with operated patients with a stable body
weight to provide information on the optimal amount of
dietary calcium. Notably, too much extra dietary calcium
may be harmful because of calcium-related constipation. It
has been shown previously that calcium salts bind to free
fatty acids and fecal bile acids in the colonic lumen, forming
calcium soaps. In other words, calcium suppresses intestinal
motility indirectly through binding at the colon level leading
to less free fatty acids and to bile acids that are toxic to the
colonic mucosa to provoke frequent and watery stools [25].
It is an open question whether increased PTH levels due
to chronic calcium malabsorption after RYGB are relevant to
future skeletal health. Bone loss after bariatric surgery can be
partly ascribed to the direct and secondary eﬀects of rapid
weight loss and partly to 2◦HPT-related bone loss. Moreover,
shortly after bariatric surgery, there will be substantial bone
loss, which is obviously driven by the catabolic state of
the ongoing weight reduction and not by 2◦HPT. Most of
this type of rapid bone loss occurs at the hip and ceases
with stabilization of body weight. The loss of bone mineral
density after surgery occurs mainly at the hip and pelvis,
varying between 5 and 10% [23, 24, 26]. However, these
analyses were performed around 12 months after surgery,
during rapid bone loss. Thus far, there are no data, for
example, after a decade available in the literature. Most of
the available data come from histological studies of operated
patients with a jejunoileal bypass, showing that full-blownJournal of Obesity 5
osteomalacia was common after this particular procedure
[27]. However, jejunoileal bypass surgery is fraught with
many long-term complications, among which is vitamin D
deﬁciency, and the operation has therefore been abandoned.
Since no histology data are available from obese patients
after RouxenY bypass surgery, the jejunoileal bypass bone
samples are unique and could help to understand some
of the skeletal health issues that should be dealt with. In
a comparative histomorphometry study in 21 patients 3–
14 years after intestinal bypass surgery for obesity, osteo-
malacia was found in one-third of all patients. Biopsies of
those without osteomalacia disclosed a marked reduction
of trabecular thickness, partly as the result of 2◦HPT and
partly because of insuﬃcient osteoblastic synthesis. This
picture diﬀers from that of age-related bone loss and
postmenopausal osteoporosis which share loss of density
rather than thickness of trabecular plates [28]. Biopsies
from 16 middle-aged males after partial gastrectomy with
Billroth II anastomosis revealed high bone turnover (leading
to bone loss) due to body weight reduction after-surgery
and/or 2◦HPT [11]. Finally, there is a histological proof for
insuﬃcient osteoblastic recruitment and activity, probably
due to deﬁcits of unidentiﬁed nutrients resulting from
the malabsorption caused by bypassing critical parts of
the small intestines [28]. In a bone biopsy study among
41 patients after partial or total biliopancreatic bypass, it
was found that defective mineralization and a decrease of
bone formation rate were present in spite of serum 25-
hydroxyvitamin D concentrations being normal [29]. These
biopsy data underscore the concept that in one way or
another essential nutrients are needed to support bone
formation.
This study has several limitations, mainly related to
its retrospective and cross-sectional design. However, it
underlines the need for more prospective intervention
studiesin gastric bypasspatients,eventhoughthisprocedure
is considered the gold standard, suggesting safety. In the
meantime, it remains advisable to consider bone mineral
density in the assessments of risk factors prior to surgery,
particularly in women.
In conclusion, 12 months after gastric bypass surgery,
there was a positive relationship between bowel habits (i.e.,
the summation of stool frequency and consistency scores)
and PTH levels with an interaction for the compliance
with calcium/Vitamin D suppletion. This ﬁnding is based
on fecal score and an arbitrarily chosen deﬁnition of
compliance. The current study underscores the importance
of professional management of bowel habits and tailor-
made calcium/vitamin D suppletion. Long-term prospective
intervention studies are critical to evaluate eﬃcacy as well as
side eﬀects and should be undertaken in the near future.
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